FLEMINGTON, N.J., Sept. 30, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today announced that Chief Executive Officer Dr. Alex Zukiwski is scheduled to present at the 13th Annual BIO Investor Forum, being held October 7-8, 2014 at The Palace Hotel in San Francisco, CA.
Dr. Zukiwski will present to attending investors on Wednesday, October 8, 2014 at 2:30 p.m. PT. During the presentation, Dr. Zukiwski will outline recent milestones achieved by Arno, the Company's business and growth strategy, as well as provide an update on the ongoing clinical development program evaluating lead compound, onapristone.
Details of the presentation are as follows:
|Date:||Wednesday, October 8, 2014|
|Time:||2:30 p.m. PT|
|Place:||The Sea Cliff Room at The Palace Hotel, San Francisco, CA|
Investors attending the Conference who would like to schedule a 1-on-1 meeting with Arno management may do so by submitting a request through the BIO Investor Forum web portal, or contacting Lee Roth of The Ruth Group at firstname.lastname@example.org.
About Arno Therapeutics
Arno Therapeutics is a clinical stage biopharmaceutical company developing innovative products for the treatment of cancer. Arno has exclusive worldwide rights to develop and market three innovative anti-cancer product candidates. These compounds are in clinical or preclinical development as product candidates to treat hematologic malignancies and solid tumors. For more information about the company, please visit www.arnothera.com.
CONTACT: The Ruth Group Lee Roth (investors) email@example.com (646) 536-7012 Kirsten Thomas (media) firstname.lastname@example.org (646) 536-7014 Arno Therapeutics Lawrence Kenyon email@example.com (862) 703-7171
Source:Arno Therapeutics Inc.